VentureMed Group, Inc.

Company Summary

VentureMed Group is a commercial stage medical device company developing innovative and minimally invasive devices for the treatment of peripheral artery disease (PAD) FLEX, the Company’s lead technology platform, is an innovative, cost-effective device for the endovascular treatment of patients suffering from PAD and arterio-venous access complications

Transaction Overview

  • $15 million growth financing led by a major European Venture fund and syndicated with US Venture

Significance of the Transaction

Fund VentureMed’s strategic clinical plan (which includes current and future trials in the US and Europe) and key operational and research and development programs Support regulatory and reimbursement initiatives for the Company’s lead technology platform, FLEX Expand the company’s worldwide commercial team

Healthios Role

If you would like to learn more information about this transaction contact us below.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Private Placement
VentureMed Group, Inc.
Has completed its $15,000,000 Series B financing led by
The undersigned acted as exclusive advisor to VentureMed Group
Read More